Large Inflow of Money Detected in C.R. Bard

C.R. Bard (BCR) : Mondays money flow points at investors jumping to buy the stock on the weakness of price. $12.34 million worth of transactions were on upticks, whereas, the downticks accounted for $11.02 million worth of transactions. The net money flow was a positive $1.31 million and the uptick to downtick ratio was 1.12. The net money flow into the stock was $0 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $0 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. C.R. Bard (BCR) was trading at $222.48, down $0.02 during day. The stock slid -0.01% over the previous days close. For the week, the stock recorded -0.02% over the previous weeks close.


Shares of CR Bard Inc. appreciated by 0.35% during the last five trading days but lost 4.3% on a 4-week basis. CR Bard Inc. is up 0.26% in the last 3-month period. Year-to-Date the stock performance stands at 17.74%.

C.R. Bard (NYSE:BCR): The stock opened at $222.66 on Monday but the bulls could not build on the opening and the stock topped out at $224.21 for the day. The stock traded down to $222.24 during the day, due to lack of any buying support eventually closed down at $222.24 with a loss of -0.12% for the day. The stock had closed at $222.50 on the previous day. The total traded volume was 281,881 shares.

In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Senior Vice President and CFO) of Bard C R Inc /Nj/, Holland Christopher S had sold 3,970 shares worth of $872,924 in a transaction dated May 27, 2016. In this transaction, 3,970 shares were sold at $219.88 per share.

C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.